Fig. 1.

(Left) Monitor-level estimated average treatment effect on the treated (“ATT”), in µg/m${}^3$; i.e., the average PM${}_{2.5}$ change attributable to COVID-19 interventions over the lockdown period. (Right) ATTs (in µg/m${}^3$) smoothed across the US using inverse distance weighting.